Loading...
OTC Markets
Totals
Securities
12,253
Dollar Vol
$2.6B
Share Vol
5.2B
Trades
360,659

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

NUNZ
Nunzia Pharmaceutical Corporation

Common Stock

Nunzia Pharmaceutical Corporation

1627 WEST 14TH STREET

LONG BEACH, CA 90813

Principal Executive Offices:

1627 West 14th Street

Long Beach, CA 90813

Last Verified 01/2023
Business Description
NUNZIA Pharmaceutical Corportion is a pharmaceutical and nutraceutical company that owns the rights to a drug that treats autism, fragile X, ADHD, and PTSD. We manufacture, market and distribute the drug Nunzia, a drug that is more effective than any drug on the market to treat the symptoms of these diseases. The drug, called Nunzia, acts to increase sensory, social, and daily living skills, as well as attention span, memory retention, focus, comprehension, and learning, all the while decreasing anxiety, stress, fixations, fidgeting, and outside detractions. The current drugs that are used to attempt to control the symptoms of these conditions are largely ineffective. Nunzia is the only drug ...
More
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Audited
CIK
0000886093
Fiscal Year End
12/31
Company Officers & Contacts
Michael Mitsunaga
President

Dr Shujie Cui
CSO

Board of Directors
Sarah Paez Gonzalas
Chairman

Michael Mitsunaga

Other Company Insiders
Sara Gonzales
LionsGate Funding Group, LLC
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Prohibited Service ProviderBF Borgers CPA PC

5400 West Cedar Avenue

Lakewood, CO 80226

Securities Counsel
Daniel King

3435 Wilshire Blvd

Suite 1111

Los Angeles, CA 90067

Profile Data
SIC - Industry Classification
2833 - Medicinal and botanicals
Incorporation Information
UT, US, 1986
Employees
2 as of 07/31/2010
Shell
No
Products and Services

Nunzia Pharmaceutical has successfully researched, developed, and patented its breakthrough solutions for anxiety-based disorders such as Autism, PTSD, ADD, OCD, and Depression. We have secured both the pharma and nutraceutical grade USA patents and plan to launch the Nutraceutical version in February 2020.

Company Facilities

Warehouse and Office

Company Notes
Formerly=Arizona Gold and Onyx Mining Co. until 12-2019
Formerly=Viking Capital Group, Inc. until 6-2010
Last Known Address (8/23/2007): 2 Lincoln Centre, Suite 300, 5420 LBJ Fwy, Dallas, TX 75240
Formerly=Institute for Financial Fitness, Inc. to 2-90
Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.